1-11 of 11
Anke Morgner
Close
Sort by
Journal Articles

Unicentric Retrospective Analysis of 130 Patients with Extramedullary Multiple Myeloma (EMM)

Dominik Zolnowski, Simone Karp, Paul Warncke, Jessica Zinn, Marcel Pannach, Regina Herbst, Annette Hänel, Anke Morgner, Stefan Ibach, Stephan Fricke, Mathias Hänel
Journal: Blood
Blood (2023) 142 (Supplement 1): 6646.
https://doi.org/10.1182/blood-2023-186266
Published: 2023
Journal Articles

Real-World Analysis of Teclistamab in 115 RRMM Patients from Germany

Christine Riedhammer, Florian Bassermann, Britta Besemer, Moritz Bewarder, Franziska Brunner, Alexander Carpinteiro, Hermann Einsele, Josefine Faltin, Jan Frenking, Deniz Gezer, Sarah Goldman-Mazur, Mathias Hanel, Marion Hoegner, K. Martin Kortüm, Jan Krönke, Miriam Kull, Theo Leitner, Christoph Mann, Rabea Mecklenbrauck, Maximilian Merz, Anke Morgner, Axel Nogai, Marc S. Raab, Raphael Teipel, Ralph Wäsch, Leo Rasche
Journal: Blood
Blood (2023) 142 (Supplement 1): 3329.
https://doi.org/10.1182/blood-2023-180032
Published: 2023
Journal Articles

Outcome of 841 Older Patients (>55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols

Nicola Goekbuget, Andreas Viardot, Björn Steffen, Joachim Hahn, Bernd Spriewald, Sonja Martin, Simon Raffel, Lino L. Teichmann, Arne Trummer, Winfried Alsdorf, Anke Morgner, Stefan Schwartz, Matthias Stelljes, Vladan Vucinic, Nael Alakel, Andrea Stoltefuß, Claudia D. Baldus, Monika Brüggemann, Hubert Serve, Dieter Hoelzer
Journal: Blood
Blood (2022) 140 (Supplement 1): 121–123.
https://doi.org/10.1182/blood-2022-158934
Published: 2022
Journal Articles

Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia

Christina Rautenberg, Friedrich Stölzel, Christoph Röllig, Matthias Stelljes, Verena I Gaidzik, Michael Lauseker, Oliver Kriege, Mareike Verbeek, Julia M. Unglaub, Felicitas Thol, Stefan W. Krause, Mathias Haenel, Charlotte Neuerburg, Vladan Vucinic, Christian Jehn, Julia Severmann, Maxi Wass, Lars Fransecky, Jens Chemnitz, Udo Holtick, Kerstin Schäfer-Eckart, Josephine Schröder, Sabrina Kraus, William Hermann Krüger, Ulrich Kaiser, Sebastian Scholl, Lea Henning, Guido Kobbe, Rainer Haas, Nael Alakel, Maximilian Alexander Röhnert, Katja Sockel, Maher Hanoun, Uwe Platzbecker, Tobias A. W. Holderried, Anke Morgner, Michael Heuser, Tim Sauer, Katharina S. Goetze, Eva Maria Wagner, Konstanze Döhner, Hartmut Döhner, Christoph Schliemann, Johannes Schetelig, Martin Bornhäuser, Ulrich Germing, Thomas Schroeder, Moritz Moritz Middeke
Journal: Blood
Blood (2021) 138 (Supplement 1): 33.
https://doi.org/10.1182/blood-2021-153440
Published: 2021
Journal Articles

Comorbidities Are Frequent in Older Patients with De Novo Acute Lymphoblastic Leukemia (ALL) and Correlate with Induction Mortality: Analysis of More Than 1200 Patients from GMALL Data Bases

Wiba Keke Wermann, Andreas Viardot, MD, Sabine Kayser, MD, Nael Alakel, MD, Ahmet Elmaagacli, Christoph Faul, MD, Walter Fiedler, MD, Heinz A. Horst, MD, Elisabeth Lange, Sonja Martin, MD, Omar Mohamed, MD, Anke Morgner, MD, Albrecht Reichle, MD, Karsten Spiekermann, MD, Bernd Spriewald, MD, Michael Starck, MD, Matthias Stelljes, MD, Arne Trummer, Vladan Vucinic, MD, Hubert Serve, MD, Dieter Hoelzer, MD PhD, Nicola Goekbuget, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 660.
https://doi.org/10.1182/blood-2018-99-111954
Published: 2018
Journal Articles

Long Term Follow up and Impact of Comorbidity Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML - Lessons Learned from the Prospective Bridge Trial -

Jan Moritz Middeke, MD, Regina Herbst, MD, Stefani Barbara Parmentier, MD, Gesine Bug, MD, Mathias Hänel, MD, Gernot Stuhler, Kerstin Schäfer-Eckart, MD, Wolf Rösler, MD, Stefan A. Klein, MD, Wolfgang Bethge, MD, Nael Alakel, MD, Markus Schaich, MD, Anke Morgner, MD, Michael Kramer, MSc, Katja Sockel, MD, Malte von Bonin, MD, Friedrich Stölzel, MD, Uwe Platzbecker, MD, Christoph Röllig, MD, Christian Thiede, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 4692.
https://doi.org/10.1182/blood.V128.22.4692.4692
Published: 2016
Journal Articles

– Updated Results from the Bridge Trial: Long-Term Survival and Impact of Donor Availability – Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML

Jan Moritz Middeke, MD, Regina Herbst, MD, Stefani B Parmentier, MD, Gesine Bug, MD, Mathias Hänel, MD, Gernot Stuhler, MD, Kerstin Schäfer-Eckart, MD, Wolf Rösler, MD, Stefan A. Klein, Wolfgang Bethge, MD, Ulrich Bitz, MD, Nael Alakel, MD, Markus Schaich, MD, Anke Morgner, MD, Michael Kramer, PhD, Uwe Platzbecker, MD, Christoph Röllig, MD, Christian Thiede, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Johannes Schetelig, MD M. Sc,
Journal: Blood
Blood (2014) 124 (21): 1204.
https://doi.org/10.1182/blood.V124.21.1204.1204
Published: 2014
Journal Articles

Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Relapsed Or Refractory AML – Results Of The Bridge Trial –

Jan Moritz Middeke, MD, Regina Herbst, MD, Stefani Parmentier, MD, Gesine Bug, MD, PhD, Mathias Hänel, MD, Gernot Stuhler, MD, Kerstin Schäfer-Eckart, MD, Wolf Rösler, MD, Stefan A. Klein, MD, Wolfgang A Bethge, MD, Ulrich Bitz, MD, Nael Alakel, MD, Markus Schaich, MD, Anke Morgner, MD, Stefan Pursche, MD, Michael Kramer, PhD, Uwe Platzbecker, MD, PhD, Christoph Röllig, MD, Christian Thiede, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Johannes Schetelig, MD, M. Sc
Journal: Blood
Blood (2013) 122 (21): 304.
https://doi.org/10.1182/blood.V122.21.304.304
Published: 2013
Journal Articles

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Nicola Goekbuget, MD, Joachim Beck, MD, Monika Brueggemann, Thomas Burmeister, MD, Eike C. Buss, MD, Norbert Frickhofen, MD, Andreas Huettmann, MD, Anke Morgner, MD, Albrecht Reichle, Ingo Schmidt-Wolf, MD, Stefan Schwartz, MD, Hubert Serve, Prof. Dr. med., Bernd M Spriewald, MD, Michael Starck, MD, Matthias Stelljes, MD, Andreas Viardot, MD, Knut Wendelin, MD, Dieter Hoelzer, MD
Journal: Blood
Blood (2012) 120 (21): 1493.
https://doi.org/10.1182/blood.V120.21.1493.1493
Published: 2012
Journal Articles

Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory AML – Interim Results of the Bridge Trial

Jan Moritz Middeke, MD, Stefani Parmentier, MD, Nael Alakel, MD, Markus Schaich, MD, Christian Thiede, Uwe Platzbecker, MD, Christoph Röllig, Mathias Hänel, MD, Gernot Stuhler, MD, Anke Morgner, MD, Uta Eulenstein, Gerhard Ehninger, Martin Bornhäuser, MD, Johannes Schetelig, MD
Journal: Blood
Blood (2012) 120 (21): 2017.
https://doi.org/10.1182/blood.V120.21.2017.2017
Published: 2012
Journal Articles

Elimination of Established Risk-Factors in Primary Central Nervous System Lymphoma - Impact of High-Dose Chemotherapy Followed by Autologous Stem-Cell Transplantaion - a Multicenter Retrospective Analysis

Elisabeth Schorb, MD, Benjamin Kasenda, MD, Johannes Atta, Nikolas von Bubnoff, MD, Thomas Elter, MD, Georg Hess, Stefan W. Krause, MD, Anke Morgner, Kaun Stephan, Kristina Fritsch, MD, Jürgen Finke, MD, Gerald Illerhaus
Journal: Blood
Blood (2011) 118 (21): 3089.
https://doi.org/10.1182/blood.V118.21.3089.3089
Published: 2011